Ming-Yeah Hu

Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial

Paul D. Miller, Gary Hattersley, Esther Yuet Ying Lau et al. · Bone · 2018 · 63 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE

Richard Eastell, Bruce Mitlak, Yamei Wang et al. · Osteoporosis International · 2019 · 50 citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +16

Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability

Eugène McCloskey, Lorraine A. Fitzpatrick, Ming-Yeah Hu et al. · Archives of Osteoporosis · 2019 · 25 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Comparison of Preoperative Alpha-blockade for Resection of Paraganglioma and Pheochromocytoma

Catherine Zhu, Joe C. Hong, Nirav Kamdar et al. · Endocrine Practice · 2022 · 12 citations · Full text

Medicine, Pharmacotherapy, Surgery +13

Intralesional collagenase Clostridium histolyticum for acute phase Peyronie’s disease: a single-center, retrospective cohort study

Ming-Yeah Hu, John T. Sigalos, Dyvon T. Walker et al. · Translational Andrology and Urology · 2022 · 12 citations · Full text

Medicine, Internal Medicine, Clinical Pharmacology +10